Publications by authors named "M Risselada"
Objective: To describe fluid dispersal and retrieval patterns in an infusion-retrieval system across various configurations and locations in a cadaveric canine model.
Study Design: Cadaveric study.
Animals: Four large breed canines.
Locally sustained release antimicrobials such as silver nanoparticles (AgNPs) might prove useful in combating local infections. Their elution has been investigated in Phosphate Buffered Saline (PBS) including from poloxamer 407 (P407). No information exists on possible interactions with proteins, nor have ultrafiltration (UF) probes been evaluated to measure Ag.
View Article and Find Full Text PDFObjective: The objectives were to (1) compare the impact of preoperative fluid resuscitation on anesthetic parameters and interventions and (2) assess the impact of preoperative resuscitation duration on the integrity of intestinal tissue and postoperative complications in dogs with gastrointestinal foreign body obstruction.
Methods: Medical records from 1 academic hospital were reviewed for 297 client-owned dogs that underwent gastrointestinal foreign body obstruction surgery between May 2017 and August 2022. Data collected included the following: signalment, preoperative fluid resuscitation, surgical findings, anesthetic parameters and interventions, postoperative complications, and timing of the first meal.
Article Synopsis
- Paraneoplastic syndromes in dogs and cats linked to thymoma include diseases like myasthenia gravis (MG), which is the most frequently reported condition associated with thymic tumors in dogs.
- The study reviewed medical records of nine dogs treated surgically for thymic epithelial tumors and analyzed their preoperative care, postoperative issues, and overall outcomes.
- Results showed that while three dogs faced immediate complications, six survived surgery, with varying degrees of recovery in MG symptoms, indicating a significant risk of complications during surgery for these conditions.
Objective: To report the clinical use, adverse events, and outcomes after using amikacin in 30% poloxamer 407 (amikacin-P407) during open wound management or in a closed wound application in dogs.
Animals: 29 client-owned dogs.
Methods: Medical records from January 2017 to August 2023 from a single hospital were reviewed for dogs that received amikacin-P407 in an open or closed wound application.